• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 7, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

New study finds that inflammatory proteins in the colon increase incrementally with weight

Bioengineer by Bioengineer
October 10, 2018
in Cancer
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Pixabay

BOSTON (Oct. 10, 2018)–Studies in mice have demonstrated that obesity-induced inflammation contributes to the risk of colorectal cancer, but evidence in humans has been scarce. A new study shows that two inflammatory proteins in the colon increase in parallel with increasing weight in humans. An incremental rise in these pro-inflammatory proteins (called cytokines) was observed along the entire spectrum of subjects' weights, which extended from lean to obese individuals. In participants with obesity, there was evidence that two pre-cancerous cellular pathways known to be triggered by these cytokines were also activated.

The study, while modest in size, provides new evidence that obesity promotes cancer through inflammation. Secondary findings suggest that NSAIDS lower the levels of pro-inflammatory proteins in the colon, regardless of a person's weight. The study is published online in advance of print in Cancer Epidemiology, Biomarkers & Prevention.

Led by Joel B. Mason, M.D., a gastroenterologist who studies nutrition and cancer prevention at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University (HNRCA), the study included 42 Caucasian participants. Sixteen research participants were lean, with a BMI between 18.1 and 24.9, while 26 participants with obesity had a BMI ranging from 30.0 to 45.7. The participants were between the ages of 45 and 70 years of age and were undergoing routine screening colonoscopies at Tufts Medical Center.

Using blood samples and colonic biopsies, the researchers determined that the concentrations of two major cytokines rose in parallel with BMI. Cytokines are proteins that mediate and regulate immunity and inflammation, among other things. In addition to evidence that they can promote cancer risk in certain tissues, pro-inflammatory cytokines have been identified as actors in insulin resistance and diabetes, as well as inflammatory disorders such as arthritis.

In addition to the work analyzing cytokines, the research team studied differences in the mucosal transcriptome between the two sets of research participants, finding changes indicative of activation in two gene expression networks that are pivotal in the development of colon cancer in the participants with obesity.

"Our results establish, for the first time, that concentrations in the colon of two major cytokines increase in concert with increasing BMI in humans. The increased concentrations are accompanied by changes in gene activation within the lining of the colon that are pro-cancerous in nature," said senior author Joel B. Mason, M.D., director of the Vitamins and Carcinogenesis Laboratory at the HNRCA.

In an effort to identify potential confounding factors, the research team determined that thirteen of the 42 study participants were also regular users of NSAIDs, such as aspirin and ibuprofen. The research team discovered that participants who took NSAIDs at least once per week, compared to those who did not, had lower levels of pro-inflammatory proteins in the colon. This pattern was consistent across the two BMI groups.

"Observational and clinical trials show aspirin can reduce the risk of colon cancer, but it continues to be controversial because of the risk of serious gastrointestinal bleeding. NSAIDs are probably working through multiple avenues, one of which is cytokines. Our observation underscores prior work that has suggested that some NSAIDs reduce the risk of colon cancer, presumed to occur through a reduction in colonic inflammation. Their use, however, has to be weighed against the potential adverse effects," said Mason.

The authors noted that the modest study size and the Caucasian population are limitations of the study, writing "given the cross-sectional nature of this study, the results cannot prove that the observed changes in the colonic transcriptome are due to the rise in cytokines…Observations from this study nevertheless underscore the potential contribution that the establishment of an inflammatory milieu in the colonic mucosa may play in explaining the enhanced risk of colon cancer due to obesity."

In the United States, colorectal cancer is the third most common cancer and the second leading cause of death among cancers that affect both men and women, according to the CDC. The American Cancer Society reports that the overall lifetime risk of developing colorectal cancer is about 1 in 22 for men and 1 in 24 for women.

The first author on the study is Anna C. Pfalzer, a Ph.D. graduate in biochemical and molecular nutrition from the Friedman School and former member of Mason's laboratory. Pfalzer is now at Vanderbilt University Medical Center. Joel Mason is also a professor at Tufts University School of Medicine and at the Friedman School of Nutrition Science and Policy at Tufts and a gastroenterologist at Tufts Medical Center.

###

This work was supported by the U.S. Department of Agriculture's Agricultural Research Service. Any opinions, findings, conclusion, or recommendations expressed in this publication are those of the authors and do not necessarily reflect the view of the U.S. Department of Agriculture.

Additional authors on the study are Keith Leung, Jimmy W. Crott, Susan J. Kim, Gail Rogers, and M. Kyla Shea of the HNRCA; Frederick K. Kamanu and Paloma E. Garcia, formerly of the HNRCA; Laurence D. Parnell of the USDA's Agricultural Research Service; Albert K. Tai of Tufts University School of Medicine, and Zhenhua Liu of the School of Public Health and Health Sciences at the University of Massachusetts, Amherst.

Pfalzer, A. C., Leung, K., Crott, J. W., Kim, S. J., Tai, A. K., Parnell, L. D., Kamanu, F. K., Liu, Z., Rogers, G., Shea, M. K., Garcia, P.E., and Mason, J. B. (Oct. 5, 2018, uncorrected proof). Incremental elevations in TNF-alpha and IL-6 in the human colon and pro-cancerous changes in the mucosal transcriptome accompany adiposity. Cancer Epidemiology, Biomarkers & Prevention. doi: 10.1158/1055-9965.EPI-18-0121

About the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University

For three decades, the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University has studied the relationship between good nutrition and good health in aging populations. Tufts research scientists work with federal agencies to establish the Dietary Guidelines, the Dietary Reference Intakes, and other significant public policies.

Media Contact

Siobhan Gallagher
[email protected]
617-636-6586
@tuftspr

http://www.tufts.edu

Related Journal Article

http://dx.doi.org/10.1158/1055-9965.EPI-18-0121

Share12Tweet7Share2ShareShareShare1

Related Posts

City of Hope Names Renowned Lung Cancer Specialist Dr. Christine M. Lovly as Director of National Thoracic Oncology Program

City of Hope Names Renowned Lung Cancer Specialist Dr. Christine M. Lovly as Director of National Thoracic Oncology Program

November 7, 2025

Supervised Exercise Enhances Strength and Physical Performance in Advanced Breast Cancer Patients

November 7, 2025

Here’s a rewritten version of the headline for a science magazine post: “The Enzyme That Defies Expectations: When Chemistry Breaks the Rules” Let me know if you want it more formal, catchy, or simplified!

November 6, 2025

Moffitt Study Uncovers Mechanism to Ignite Immune Hotspots Targeting Tumors

November 6, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    313 shares
    Share 125 Tweet 78
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    206 shares
    Share 82 Tweet 52
  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1301 shares
    Share 520 Tweet 325
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    138 shares
    Share 55 Tweet 35

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Radiative Coupled Evaporative Cooling Hydrogel Enables Above-Ambient Heat Dissipation and Enhanced Flame Retardancy

New Study Reveals How Variations Between Preclinical Models and Humans Can Predict Drug Toxicity

Exploring Complementary and Alternative Medicine in Autistic Preschoolers

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 69 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.